# Gavreto

NDC: 50242-210
Generic name: Pralsetinib
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20210701
Marketing ended: 20260930
FDA application: NDA213721

## Active ingredients

- PRALSETINIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-210"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-210
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=59984249-e3ff-4f97-8d7a-c1a905d604a8